4Filing Date: Sep 3, 2026
Lab (LH)
Statement of Changes in Beneficial Ownership
View SEC Filing
ACC: 0000920148-26-000190
Total Value$0
Trades1
Insiders1
Transaction Details
Caveney Brian J
EVP, Pres of BLS, CMO & CSO·Direct
Grant · Acquire
Restricted Stock UnitDerivative
Shares+3.00K
Price$0.00
Total Value$0
Shares Owned After7.17K
Transaction DateSep 1, 2026
Footnotes ▸
Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. | The Restricted Stock Units vest in three equal annual installments beginning on September 1, 2027. | The Restricted Stock Units vest in three equal annual installments beginning on September 1, 2027. | This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
Post-Transaction Holdings
Caveney Brian J · EVP, Pres of BLS, CMO & CSO
| Security | Shares | Change |
|---|---|---|
| Restricted Stock Unit | 7.17K | +3.00K (71.94%) |
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership ===
Document Type: 4
Period of Report: 2026-09-01
10b5-1 Pre-arranged Plan: No
--- Issuer ---
Name: LABCORP HOLDINGS INC. (LH)
CIK: 0000920148
--- Reporting Owner ---
Name: Caveney Brian J
CIK: 0001717915
Role: Officer (EVP, Pres of BLS, CMO & CSO)
--- Derivative Transactions ---
[Transaction #1]
Security: Restricted Stock Unit
Date: 2026-09-01 | Code: A (Grant or award)
Shares: +3,000 | Price: $0.00
Shares Owned After: 7,170 | Ownership: D (Direct)
Footnotes:
[F1] Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.
[F2] The Restricted Stock Units vest in three equal annual installments beginning on September 1, 2027.
[F2] The Restricted Stock Units vest in three equal annual installments beginning on September 1, 2027.
[F3] This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
--- Footnotes (Complete Index) ---
F1: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.
F2: The Restricted Stock Units vest in three equal annual installments beginning on September 1, 2027.
F3: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
--- Signature ---
/s/ /s/ Kathryn W. Kyle, Attorney-in-Fact for Brian J. Caveney (2026-09-03)